Brought to you by 
HiFiBio raises $37.5mm in Series B round
18 May 2018
Executive Summary
Therapeutic antibody developer HiFiBio Therapeutics raised $37.5mm through an oversubscribed Series B round led by Sequoia China and LYFE Capital. New investors Legend Star Capital and Proxima Ventures also participated, along with Series A backers VI Ventures (Virtus Inspire) and Nest.Bio Ventures.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
HiFiBio raises $37.5mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice